Nucleic Acid Isolation and Purification Market worth $3,106.28 Million by 2018

Monday 12 May 2014, Amsterdam

The “Nucleic Acid Isolation and Purification Market by Technology (Column based, Reagent based, Magnetic bead based), Consumables & Instruments, by Application (Plasmid DNA isolation, MIRNA isolation, Total RNA isolation), End users - Global Forecasts to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global nucleic acid isolation and purification market along with the estimates and forecasts of the revenue and share analysis.

This report studies the global nucleic acid isolation and purification market over the forecast period of 2013 to 2018. This market is valued at an estimated $2,103.39 million in 2013.

The report segments this market by technology, application, product, end user, and geography. The technology segments included in this report are column–based, magnetic bead-based, reagent-based, and other (anion exchange-based, glass fiber-based) for DNA and RNA isolation and purification. Of these, the column-based technology for DNA isolation and purification commands the largest share of the global nucleic acid isolation and purification market and is also poised to grow at the healthy CAGR between 2013 and 2018. However, magnetic bead-based technology for DNA isolation will grow at highest CAGR during the forecasted period. Use of purified form of DNA in research for various downstream processes is the primary growth driver of this technology segment.

The application segments included in this report are blood DNA isolation and purification, genomic DNA isolation and purification, micro RNA isolation and purification, mRNA isolation and purification, plasmid DNA isolation and purification, total RNA isolation and purification, and PCR clean up. The plasmid DNA isolation and purification segment commands the largest share of the global nucleic acid isolation and purification market, while micro RNA isolation and purification is poised to grow at the highest CAGR between 2013 and 2018 followed by PCR clean up. The increasing research activities and use of nucleic acid test in molecular diagnostics are driving the growth of this segment.

The end-user segments included in this report are academic research, hospitals and diagnostic centers, pharmaceutical and biotechnology companies, contract research organizations, and other end users such as food testing and forensic laboratories. Of these, the academic research end-user segment commands the largest share of the global nucleic acid isolation and purification market, while the hospitals and diagnostic centers end-user segment is poised to grow at the highest CAGR between 2013 and 2018. This growth will be attributed to the increasing applications of nucleic acid tests in molecular diagnostics.

Under the geography segment, the global nucleic acid isolation and purification market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). The North American geographic segment is further divided into regional segments of the U.S. and Canada. The European geographic segment is further divided into regional segments of Germany, France, Italy, Spain, the U.K., and the Rest of Europe. The Asian segment includes regional segments of India, China, Japan, and the Rest of Asia.

The significance of pure nucleic acid for applications in the pharmaceuticals and biotechnological industry has fueled its demand in the research and life science markets. The isolation of nucleic acid in the pure form is needed for drug discovery, molecular diagnostics, and genotypic applications. The technological innovations and advancements; and government initiatives in form of funding for research projects are the factors driving this market. Furthermore, the increasing use of nucleic acid-based tests in diagnosis is expected to drive this market in coming future.

The major players in the nucleic acid isolation and purification market include Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Danaher Corporation (U.S.), Illumina Inc. (U.S.), Life Technologies (U.S.), Promega Corporation (U.S.), Qiagen (Netherlands), Roche Applied Sciences (Germany), and Thermo Fischer Scientific Inc. (U.S.).